InterVenn Biosciences Advances Glycoproteomics to Propel Understanding and Find New Therapies in Complex Diseases

Published: 14/01/2020
InterVenn Biosciences Advances Glycoproteomics to Propel Understanding and Find New Therapies in Complex Diseases
Source: WWW.BUSINESSWIRE.COM

SAN FRANCISCO--(BUSINESS WIRE)-- #AI--InterVenn BioSciences continues to make progress in various diseases through the use of glycomics.

Read more
Related news
Comment
FACEBOOK